HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis.

HIV-infection is an important risk factor for developing Kaposi sarcoma (KS), but it is unclear whether HIV-positive persons are also at increased risk of co-infection with human herpesvirus 8 (HHV-8), the infectious cause of KS. We systematically searched literature up to December 2012 and included studies reporting HHV-8 seroprevalence for HIV-positive and HIV-negative persons. We used random-effects meta-analysis to combine odds ratios (ORs) of the association between HIV and HHV-8 seropositivity and conducted random-effects meta-regression to identify sources of heterogeneity. We included 93 studies with 58,357 participants from 32 countries in sub-Saharan Africa, North and South America, Europe, Asia, and Australia. Overall, HIV-positive persons were more likely to be HHV-8 seropositive than HIV-negative persons (OR 1.99, 95% confidence interval [CI] 1.70-2.34) with considerable heterogeneity among studies (I(2) 84%). The association was strongest in men who have sex with men (MSM, OR 3.95, 95% CI 2.92-5.35), patients with hemophilia (OR 3.11, 95% CI 1.19-8.11), and children (OR 2.45, 95% CI 1.58-3.81), but weaker in heterosexuals who engage in low-risk (OR 1.42, 95% CI 1.16-1.74) or high-risk sexual behavior (OR 1.66, 95% CI 1.27-2.17), persons who inject drugs (OR 1.66, 95% CI 1.28-2.14), and pregnant women (OR 1.68, 95% CI 1.15-2.47), p value for interaction <0.001. In conclusion, HIV-infection was associated with an increased HHV-8 seroprevalence in all population groups examined. A better understanding of HHV-8 transmission in different age and behavioral groups is needed to develop strategies to prevent HHV-8 transmission.

Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

All forms of Kaposi sarcoma (KS) are more common in men than in women. It is unknown if this is due to a higher prevalence of human herpesvirus 8 (HHV-8), the underlying cause of KS, in men compared to women. We did a systematic review and meta-analysis to examine the association between HHV-8 seropositivity and gender in the general population. Studies in selected populations like for example, blood donors, hospital patients, and men who have sex with men were excluded. We searched Medline and Embase from January 1994 to February 2015. We included observational studies that recruited participants from the general population and reported HHV-8 seroprevalence for men and women or boys and girls. We used random-effects meta-analysis to pool odds ratios (OR) of the association between HHV-8 and gender. We used meta-regression to identify effect modifiers, including age, geographical region and type of HHV-8 antibody test. We included 22 studies, with 36,175 participants. Men from sub-Saharan Africa (SSA) (OR 1.21, 95% confidence interval [CI] 1.09-1.34), but not men from elsewhere (OR 0.94, 95% CI 0.83-1.06), were more likely to be HHV-8 seropositive than women (p value for interaction=0.010). There was no difference in HHV-8 seroprevalence between boys and girls from SSA (OR 0.90, 95% CI 0.72-1.13). The type of HHV-8 assay did not affect the overall results. A higher HHV-8 seroprevalence in men than women in SSA may partially explain why men have higher KS risk in this region. This article is protected by copyright. All rights reserved.

Fasting blood glucose and 8-year mortality in the hypertension detection follow-up program population

This study analyzed the relationship between fasting blood glucose (FBG) and 8-year mortality in the Hypertension Detection Follow-up Program (HDFP) population. Fasting blood glucose (FBG) was examined both as a continuous variable and by specified FBG strata: Normal (FBG 60–100 mg/dL), Impaired (FBG ≥100 and ≤125 mg/dL), and Diabetic (FBG>125 mg/dL or pre-existing diabetes) subgroups. The relationship between type 2 diabetes was examined with all-cause mortality. This thesis described and compared the characteristics of fasting blood glucose strata by recognized glucose cut-points; described the mortality rates in the various fasting blood glucose strata using Kaplan-Meier mortality curves, and compared the mortality risk of various strata using Cox Regression analysis. Overall, mortality was significantly greater among Referred Care (RC) participants compared to Stepped Care (SC) {HR = 1.17; 95% CI (1.052,1.309); p-value = 0.004}, as reported by the HDFP investigators in 1979. Compared with SC participants, the RC mortality rate was significantly higher for the Normal FBG group {HR = 1.18; 95% CI (1.029,1.363); p-value = 0.019} and the Impaired FBG group, {HR = 1.34; 95% CI (1.036,1.734); p-value = 0.026,}. However, for the diabetic group, 8-year mortality did not differ significantly between the RC and SC groups after adjusting for race, gender, age, smoking status among Diabetic individuals {HR = 1.03; 95% CI (0.816,1.303); p-value = 0.798}. This latter finding is possibly due to a lack of a treatment difference of hypertension among Diabetic participants in both RC and SC groups. The largest difference in mortality between RC and SC was in the Impaired subgroup, suggesting that hypertensive patients with FBG between 100 and 125 mg/dL would benefit from aggressive antihypertensive therapy.^

Eocene calcareous nannofossils in DSDP Holes 95-612 and 95-613

Lower Eocene calcareous nannofossil limestone cored at DSDP Site 612 on the middle slope off New Jersey represents an almost complete biostratigraphic sequence; only the lowest biozone (CP9a; NP10*) was not recovered. The thickness of the strata (198 m), the good preservation of the nannofossils, and the lack of long hiatuses justify the acceptance of this section as a lower Eocene reference for the western North Atlantic margin. The widely recognized and very similar nannofossil zonations of Martini (NP zones) and Bukry-Okada (CP zones) are emended slightly to make their lower Eocene biozones coeval; in addition, five new subzones are erected that subdivide zones CP10 and CPU (NP12 and NP13). Established biozone names are retained as they are altered little in concept, but alphanumeric code systems are changed somewhat by appending an asterisk (*) to identify zones that are emended. Zone CP10* (NP12*) is divided into two parts, the Lophodolithus nascens Subzone (CP10*a; NP12*a) and the Helicosphaera seminulum Subzone (CP10*b; NP12*b). Zone CPU* (NP13*) is divided into three parts, the Helicosphaera lophota Subzone (CP11*a; NP13*a), the Cyclicargolithuspseudogammation Subzone (CP11*b; NP13*b), and the Rhabdosphaera tenuis Subzone (CP11*c; NP13*c). At Site 612, a time-depth curve based on nannofossil datums dated in previous studies reveals a smoothly declining sediment accumulation rate, from 4.9 cm/10**3yr in CP10* (NP12*) to 2.8 cm/103 yr. in CP12* (NP14*). The ages of first-occurrence datums not previously dated are approximated by projection onto this timedepth curve and are as follows: Helicosphaera seminulum, 55.0 Ma; Helicosphaera lophota, 54.5 Ma; Cyclicargolithus pseudogammation, 53.7 Ma; Rhabdosphaera tenuis, 52.6 Ma; and Rhabdosphaera inflata, 50.2 Ma. At nearby Site 613 on the upper rise, strata of similar age, 139 m thick, contain an unconformity representing Subzone CPll*b (NP13*b) and a hiatus of approximately 1.1 m.y. duration. The sediment accumulation rate in the lower part of this section (9.7 cm/10**3yr.) is twice that observed for equivalent strata at Site 612. The hiatus and the heightened sediment accumulation rate at Site 613 probably represent the effects of episodic mass wasting on the early Eocene continental slope and rise.